Header cover image

U.K. (FTSE) Healthtech Industry Analysis

UpdatedMay 26, 2022
DataAggregated Company Financials
Companies10
  • 7D-0.5%
  • 3M-14.4%
  • 1Y-41.0%
  • YTD-32.5%

Over the last 7 days, the Healthtech industry has remained flat, although notably Renalytix declined by 13%. As for the longer term, the industry has declined 41% in the last year. As for the next few years, earnings are expected to grow by 19% per annum.

Industry Valuation and Performance

Has the U.K. Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sat, 28 May 2022UKĀ£1.7bUKĀ£341.8m-UKĀ£47,608,841.0076.1x
Mon, 25 Apr 2022UKĀ£2.0bUKĀ£326.2m-UKĀ£46,912,544.0098.8x
Wed, 23 Mar 2022UKĀ£1.9bUKĀ£321.1m-UKĀ£41,901,715.0085.5x
Fri, 18 Feb 2022UKĀ£2.0bUKĀ£284.3m-UKĀ£38,700,606.0081.6x
Sun, 16 Jan 2022UKĀ£2.4bUKĀ£285.4m-UKĀ£30,979,666.00102.4x
Tue, 14 Dec 2021UKĀ£2.5bUKĀ£287.3m-UKĀ£31,587,163.0094.9x
Thu, 11 Nov 2021UKĀ£2.8bUKĀ£281.8m-UKĀ£26,269,092.0099x
Sat, 09 Oct 2021UKĀ£2.8bUKĀ£280.9m-UKĀ£20,224,932.0098.8x
Mon, 06 Sep 2021UKĀ£3.0bUKĀ£266.2m-UKĀ£11,868,606.4869.5x
Wed, 04 Aug 2021UKĀ£3.0bUKĀ£266.2m-UKĀ£11,868,606.4865.9x
Sat, 08 May 2021UKĀ£2.9bUKĀ£262.9m-UKĀ£11,200,303.4858.5x
Tue, 09 Feb 2021UKĀ£2.5bUKĀ£259.1m-UKĀ£5,185,482.4045.5x
Mon, 02 Nov 2020UKĀ£1.7bUKĀ£259.8m-UKĀ£5,525,994.7531.2x
Thu, 06 Aug 2020UKĀ£1.7bUKĀ£259.0m-UKĀ£2,284,079.9631.9x
Sun, 10 May 2020UKĀ£1.6bUKĀ£257.0mUKĀ£26.1m26.9x
Sat, 01 Feb 2020UKĀ£1.6bUKĀ£247.2m-UKĀ£3,229,722.5838.2x
Tue, 05 Nov 2019UKĀ£1.7bUKĀ£247.4mUKĀ£3.1m50.9x
Fri, 09 Aug 2019UKĀ£1.8bUKĀ£247.7mUKĀ£5.9m36.7x
Median PE Ratio

34.3x


Total Market Cap: UKĀ£1.8bTotal Earnings: UKĀ£10.1mTotal Revenue: UKĀ£243.0mTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthtech Industry Median PE3Y Average 53.3x202020212022
Current Industry PE
  • Investors are optimistic on the industry, and appear confident in long-term growth rates.
  • The industry is trading at a PE ratio of 76.1x which is higher than its 3-year average PE of 53.3x.
Past Earnings Growth
  • Total earnings for the Health Care Technology industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.K. Healthtech compare with similar industries?

GB Market1.04%
Healthcare2.17%
Healthtech-0.53%
Healthtech-0.53%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
INS InstemUKĀ£6.907.8%
+UKĀ£11.3m
1.1%PS93.3x
EMIS EMIS GroupUKĀ£13.061.2%
+UKĀ£10.1m
10.1%PS28.3x
CRW CranewareUKĀ£13.901.5%
+UKĀ£7.0m
-41.6%PS67.2x
FDBK FeedbackUKĀ£0.00637.8%
+UKĀ£1.2m
-41.9%PS56.8x
IQAI IQ-AIUKĀ£0.042.6%
+UKĀ£182.6k
-46.7%PS14x
Simply Wall Stā„¢
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IQAI

UKĀ£0.04

IQ-AI

7D

2.6%

1Y

-46.7%

RENX

UKĀ£1.40

Renalytix

7D

-12.5%

1Y

-88.1%